Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

  • Read more about LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients

  • Read more about Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients

Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19

  • Read more about Exploratory Efficacy of N-Acetylcysteine in Patients With History of COVID-19

Chinese Herbal Formula for COVID-19

  • Read more about Chinese Herbal Formula for COVID-19

Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated

  • Read more about Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated

Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics

  • Read more about Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics

Neutralizing Antibody Level After COVID-19 Vaccination

  • Read more about Neutralizing Antibody Level After COVID-19 Vaccination

Partnerships to Address COVID-19 Inequities

  • Read more about Partnerships to Address COVID-19 Inequities

'Long COVID-19' in Suffolk and North Essex: Defining the Disease and Optimising Outcomes

  • Read more about 'Long COVID-19' in Suffolk and North Essex: Defining the Disease and Optimising Outcomes

Cognitive Rehabilitation in Post-COVID-19 Condition

  • Read more about Cognitive Rehabilitation in Post-COVID-19 Condition

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 77
  • Page 78
  • Page 79
  • Page 80
  • Current page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA